Key Catalysts for Traders and Investors: 1. US Supreme Court decision Roe v Wade to spur an uptick in condom usage (NA and EMEA region) 2. Recent fall of freight rates as well as raw material costs such as rubber and silicone oil (been a major concern due to supply chain issues since Q2 FY20). This will greatly reduce distribution expenses, manufacturing costs. Likely to contribute towards at least ~8% of their net profits in FY23 3. Consolidation of major industry players such as Reckitt Benkinser and more to contribute towards market share growth for Karex 4. High management confidence as reflected in previous briefing and earning calls. The chairman is very confident about the company outlook moving forward. Utilization rate has already improved signficantly 5. The company is actively putting CAPEX into improving production capacity for other alternative products apart from its core product. (The Edge: The planned RM40 million glove manufacturing facility was announced in August 2020, during the height of the Covid-19 pandemic. The factory is located in Hatyai, Thailand, with a planned capacity of up to 2.5 billion pieces annually.) 6. No need to raise equity or share issuance to pay debt. Cash position looks good and balance sheet remains healthy despite heavy investments. 7. Strong macroeconomic support. The healthcare sector is generally resistant against any form of economic downturn.
This will be another high conviction play like Kawan Food. No short-term trade for me, at least 6 month hold
@greatwall yes. You think insiders keep buying up to RM0.70+ for nothing? Not just CEO bought, his entire family bought already. Not just one account, across many CDS and nominee account as well as proxy. If you still wait on the sidelines, you will miss out. One price target upgrade from Walter AW, we fly again
This stock is not only supported by fundamentals, the technical setup is absolutely perfect. Karex Berhad was recently featured on The Edge hard-copy newspaper. All the sell-side analysts LOVE this stock. Buy-side is not done buying yet. Recession-proof companies will still remain attractive in the next few quarters moving forward (Global recession will not be FULLY priced in until Q3 2023 at least).
i3investor Best Call Award - Walter AW Who cares about The Edge Best Call Award. Walter AW is the best analyst in my heart. My Man Deserves his Bonus Give him 24-month bonus
I took a relatively small position in Karex on the last day before the Christmas break at 68.5 cents, purely on technical analysis. My target is 82 cents (on technicals) but will monitor it as to whether it does or doesn't get within that price target, to either hold or sell.
Some mustang only want karex to get free condominium pictures printed on the boxes. Birdie mustang is faster changing condominiums pictures on the boxes. You all know what is free inside the boxes. Haha
Economy no good, people less using Karex. Can’t focus. No mood. Hormones drained. Money problems. Business problems. Kids ask for money. So many chains of problems arising. So Karex usage only little bit lah.
Economy is good. More people using Karex. People Can focus activities . More mood for activities. Hormones increasing. No Money problems. No Business problems. Kids getting more money. So many chains of problems solved. So Karex usage A LOT lah.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
wallstreetrookieNEW
608 posts
Posted by wallstreetrookieNEW > 2022-12-19 10:12 | Report Abuse
I would add more Karex shares if it dips below RM0.70. Add on weakness